Metabolic Matters MASLD in Obesity: Early Detection and Management

Metabolic Matters MASLD in Obesity: Early Detection and Management is organized by DKBmed.

Release date: December 15, 2025
Expiration date: December 14, 2026

Description:
This two-part on-demand webcast series will change the way you diagnose and manage Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD). MASLD is the most common cause of chronic liver disease worldwide and growing in prevalence, but as many as half of patients may be undiagnosed. MASLD is hidden in plain sight.

In this session recorded at ObesityWeek® 2025, you’ll meet a patient and walk through their diagnosis and treatment. You’ll discover:

• The surprising prevalence of MASLD
• Accurate testing methods and which patients to screen
• Therapeutic targets that have the biggest impact
• Emerging treatments that could change the landscape

Educational Objectives:

• Identify and articulate the pathophysiologic mechanisms that underlie the development and progression of MASLD.? 
• Evaluate and apply evidence-based strategies to improve detection of MASLD, MASH, and fibrosis.? 
• Analyze the natural history and clinical consequences of MASLD to differentiate disease stages and describe outcomes.? 
• Critically appraise and synthesize safety and efficacy findings from recent clinical trials of dual GLP-1/glucagon receptor agonists for MASH treatment.?